News Resolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023 Staff March 30, 2023 Please read the announcement in PDF Attachment 2023_51_Novozymes_extraordinary_shareholders_meeting_resolutions Continue Reading Previous Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholdersNext Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call More Stories News FendX Technologies Announces Second Closing of Non-Brokered Private Placement and Announces Further Upsizing to $2 million Staff March 25, 2024 Cancer Diagnostics DNA Healthcare News VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update Staff March 25, 2024 News Brüush Receives Additional Delisting Notification to Address at Hearing Staff March 25, 2024